EGF c.31G>C ;(p.V11L)

Variant ID: 4-110834522-G-C

NM_001963.4(EGF):c.31G>C;(p.V11L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021-10-19

Variant appearance in text: EGF: V11L
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 11
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021

Variant appearance in text: EGF: V11L
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 11
View BVdb publication page



Acetylcholine signaling system in progression of lung cancers.

Pharmacology & Therapeutics
Friedman, Jamie R JR; Richbart, Stephen D SD; Merritt, Justin C JC; Brown, Kathleen C KC; Nolan, Nicholas A NA; Akers, Austin T AT; Lau, Jamie K JK; Robateau, Zachary R ZR; Miles, Sarah L SL; Dasgupta, Piyali P
Publication Date: 2019-02

Variant appearance in text: EGF: V11L
PubMed Link: 30291908
Variant Present in the following documents:
  • Main text
View BVdb publication page